PRCT Q3 2021 Earnings — PROCEPT BioRobotics Corporation Revenue & Financial Results | Market Cap Arena

PRCTPROCEPT BioRobotics Corporation

$1B

Q3 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$9M+311.4% YoY

Gross Profit

$4M48.9% margin

Operating Income

-$13M-147.6% margin

Net Income

-$14M-162.7% margin

EPS (Diluted)

$-0.33

QoQ Revenue Growth

+2.3%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$925,000

Balance Sheet

Total Assets

$351M

Total Liabilities

$68M

Stockholders' Equity

$283M

Cash & Equivalents

$320M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$2M	+311.4%
Gross Profit	$4M	-$31,000	+13777.4%
Operating Income	-$13M	-$11M	-16.6%
Net Income	-$14M	-$12M	-17.4%

Geographic Segments

UNITED STATES

$5M91%

Outside the United States

$481,0009%